Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies

Abstract

Diagnostic accuracy for hysteroscopy is high for endometrial cancer, polyps and submucous myomas, but only moderate for endometrial hyperplasia.

The Role of Hysteroscopy In Endometrial Cancer

“…Hysteroscopy performed even better, when evaluated as a diagnostic tool for endometrial cancer, in terms of specificity. Despite a previous report demonstrating that hysteroscopy performs better in diagnosing rather than excluding endometrial cancer [22] in women with AUB, Gkrozou et al showed rather the contrary [4]. In their analysis, hys-teroscopy is more efficient in excluding rather than diagnosing endometrial cancer cases.…”

“…In the meta-analysis from Gkrozou et al, hysteroscopy was found to have higher specificity than sensitivity when diagnosing endometrial cancer [4]. The 95 % CI was also wider for sensitivity than specificity.…”

“…In a very recent meta-analysis from the Department of Obstetrics & Gynecology of the University of Ioannina Greece [4] for sensitivity and specificity, respectively, using the Moses-Littenberg method. The divergence was considerable in the case of sensitivity but not for specificity.…”

“…Furthermore, the diagnostic accuracy of hysteroscopy may vary according to the menopausal status and the experience of the physician performing the examination. Hysteroscopy is a subjective diagnostic test; its result depends on the experience, the knowledge and the capability of the http://scidoc.org/IJCTD.php performing physician [4].…”

Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study

“…However, a recent meta- Neutral or somewhat disagree 4 11 analysis to determine the accuracy of hysteroscopy in diagnosing endometrial cancer, hyperplasia, polyps and submucous myomas, concluded that diagnostic accuracy for hysteroscopy is high for endometrial cancer, polyps and submucous myomas, but only moderate for endometrial hyperplasia [15].…”